Investigating the effects of RSV vaccination during pregnancy on infant health outcomes
Neonatal, Lactation, and Child Health Outcomes Following RSV Vaccination During Pregnancy
This study is looking at how getting the RSV vaccine while pregnant can help keep newborns and young kids healthy, especially for moms at higher risk of having preterm babies, and it aims to reassure pregnant women about the vaccine's safety and benefits for their little ones.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Healthpartners Institute NIH-funded |
| Lab location | 1 site (Bloomington, UNITED STATES) |
| Project ID | NIH-11166631 on NIH RePORTER |
What this research studies
This research examines how receiving the RSV vaccine during pregnancy affects the health of newborns and young children. It focuses on understanding the safety and effectiveness of the vaccine, particularly for mothers at high risk for preterm birth and its impact on breastfeeding and long-term child development. By collecting real-world data, the study aims to address concerns about the vaccine's safety and improve confidence in its use among pregnant individuals. Participants will be monitored for various health outcomes in their infants, including growth and allergic conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant individuals, particularly those who are at high risk for preterm birth, who are considering or have received the RSV vaccine.
Not a fit: Patients who are not pregnant or those who do not plan to have children in the near future may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the safety profile of the RSV vaccine, leading to increased vaccination rates and better health outcomes for infants.
How similar studies have performed: Previous research has shown promising results regarding the safety and efficacy of vaccines during pregnancy, but this specific investigation into RSV vaccination is novel and aims to fill existing knowledge gaps.
Where this research is happening
Bloomington, UNITED STATES
- Healthpartners Institute — Bloomington, United States (Active)
Researchers
- Principal investigator: Palmsten, Kristin — Healthpartners Institute
- Study coordinator: Palmsten, Kristin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.